BioSpace News Archive

Blue Earth Diagnostics today highlighted presentations at the upcoming Society of Nuclear Medicine and Molecular Imaging Annual Meeting to be held in a virtual format from June 11 to 15, 2021.

Evaluating the safety, tolerability, and efficacy of intravenous (IV) temanogrel for cMVO in adult participants undergoing percutaneous coronary intervention (PCI).

Collaboration with 23andMe enables robust sharing of de-identified genetic data with researchers worldwide through the Fox Insight Data Exploration Network (Fox DEN)

Lux Capital, Mubadala Capital, Obvious Ventures, and DCVC among founding group supporting underrepresented founders building next-generation healthcare companies

Delcath Systems, Inc., an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effect after the US market opens on June 28, according to a preliminary list of additions posted June 4.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), today announced that the next planned interim analysis in its Phase 3 trial of Mino-Lok.

Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and American & Efird, (A&E), the world’s foremost thread manufacturer, today announced A&E’s INTEGRITY™ advanced identification thread technology is available for its ECO100 recycled sewing thread line

Mach7 Technologies, a company specializing in innovative medical imaging and data management solutions for healthcare providers, announced that it has welcomed Mr. David Madaffri to the company as its new Senior Vice President of Global Sales.

A study published in the Journal of Clinical Psychopharmacology found that an FDA cleared, computer-based, objective measurement of attention-deficit/hyperactivity disorder (ADHD) symptoms was more sensitive to medication effects than patient self-rating, at both one-month and six-month follow-up visits